Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
NCT06279793Phase 2Recruiting
- Sponsor
- GCP-Service International
- Start
- Feb 2024
- Primary completion
- Mar 2030
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 2, randomised trial of fish oil concentrate in Atrial fibrillation (AFib) (2 arms), sponsored by GCP-Service International. Primary endpoint: Atrial fibrillation at 7 days. Started Feb 2024; status: recruiting.
02
Drugs
fish oil concentrate
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06279793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06279793.